View ValuationCosmax 향후 성장Future 기준 점검 2/6Cosmax (는) 각각 연간 10.5% 및 10.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 10.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 23.4% 로 예상됩니다.핵심 정보10.5%이익 성장률10.41%EPS 성장률Personal Products 이익 성장30.8%매출 성장률10.3%향후 자기자본이익률23.39%애널리스트 커버리지Good마지막 업데이트19 May 2026최근 향후 성장 업데이트Major Estimate Revision • Jan 27Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩6,824 to ₩5,749 per share. Revenue forecast steady at ₩2.40b. Net income forecast to grow 149% next year vs 61% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩242,500. Share price rose 2.9% to ₩189,600 over the past week.Price Target Changed • Nov 12Price target decreased by 10% to ₩256,280Down from ₩285,600, the current price target is an average from 25 analysts. New target price is 62% above last closing price of ₩158,000. Stock is up 19% over the past year. The company is forecast to post earnings per share of ₩6,484 for next year compared to ₩7,562 last year.Major Estimate Revision • Nov 11Consensus EPS estimates fall by 28%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩9,309 to ₩6,713 per share. Revenue forecast steady at ₩2.45b. Net income forecast to grow 92% next year vs 72% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩280,160. Share price fell 22% to ₩156,500 over the past week.Major Estimate Revision • Aug 13Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩2.55b to ₩2.52b. EPS estimate also fell from ₩11,353 per share to ₩10,172 per share. Net income forecast to grow 67% next year vs 32% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩295,167 to ₩288,000. Share price fell 25% to ₩191,600 over the past week.Price Target Changed • Jun 18Price target increased by 9.5% to ₩261,571Up from ₩238,952, the current price target is an average from 21 analysts. New target price is approximately in line with last closing price of ₩262,000. Stock is up 40% over the past year. The company is forecast to post earnings per share of ₩11,419 for next year compared to ₩7,562 last year.Price Target Changed • May 19Price target increased by 7.1% to ₩227,714Up from ₩212,667, the current price target is an average from 21 analysts. New target price is 11% above last closing price of ₩205,000. Stock is up 24% over the past year. The company is forecast to post earnings per share of ₩11,055 for next year compared to ₩7,562 last year.모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • May 18Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩180,200, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 115% over the past three years.분석 기사 • Mar 25Cosmax's (KRX:192820) Solid Profits Have Weak FundamentalsCosmax, Inc.'s ( KRX:192820 ) stock was strong after they recently reported robust earnings. However, our analysis...Reported Earnings • Mar 24Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: ₩10,847 (up from ₩7,562 in FY 2024). Revenue: ₩2.40t (up 11% from FY 2024). Net income: ₩123.1b (up 43% from FY 2024). Profit margin: 5.1% (up from 4.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 95%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩198,700, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 157% over the past three years.공시 • Mar 07+ 1 more updateCosmax, Inc. announces Annual dividendCosmax, Inc. announced Annual dividend of KRW 3300.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩160,700, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 102% over the past three years.공시 • Feb 23Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl.Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl on February 23, 2026. Through this acquisition, COSMAX seeks to leverage the strengths of both companies to create significant synergies. For the period ending December 31, 2025, Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl reported total revenue of €10.5 million. COSMAX plans to satisfy the conditions precedent, including securing approval from the Italian government, by March, to finalize the transaction.Major Estimate Revision • Jan 27Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩6,824 to ₩5,749 per share. Revenue forecast steady at ₩2.40b. Net income forecast to grow 149% next year vs 61% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩242,500. Share price rose 2.9% to ₩189,600 over the past week.분석 기사 • Jan 02These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • Dec 17Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) P/EWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 13x, you may consider...분석 기사 • Nov 20We Like Cosmax's (KRX:192820) Returns And Here's How They're TrendingIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...Reported Earnings • Nov 19Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: ₩789 (down from ₩1,856 in 3Q 2024). Revenue: ₩585.6b (up 11% from 3Q 2024). Net income: ₩8.96b (down 57% from 3Q 2024). Profit margin: 1.5% (down from 4.0% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 76%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • Nov 12Price target decreased by 10% to ₩256,280Down from ₩285,600, the current price target is an average from 25 analysts. New target price is 62% above last closing price of ₩158,000. Stock is up 19% over the past year. The company is forecast to post earnings per share of ₩6,484 for next year compared to ₩7,562 last year.Major Estimate Revision • Nov 11Consensus EPS estimates fall by 28%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩9,309 to ₩6,713 per share. Revenue forecast steady at ₩2.45b. Net income forecast to grow 92% next year vs 72% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩280,160. Share price fell 22% to ₩156,500 over the past week.분석 기사 • Nov 05When Should You Buy Cosmax, Inc. (KRX:192820)?Cosmax, Inc. ( KRX:192820 ), is not the largest company out there, but it saw significant share price movement during...분석 기사 • Sep 17Is Cosmax, Inc. (KRX:192820) Trading At A 47% Discount?Key Insights Cosmax's estimated fair value is ₩417,766 based on 2 Stage Free Cash Flow to Equity Cosmax's ₩222,500...분석 기사 • Sep 03These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt Reasonably WellLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...New Risk • Aug 19New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.6% operating cash flow to total debt). High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change).Reported Earnings • Aug 19Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: ₩1,844 (down from ₩2,965 in 2Q 2024). Revenue: ₩623.6b (up 13% from 2Q 2024). Net income: ₩20.9b (down 38% from 2Q 2024). Profit margin: 3.4% (down from 6.1% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.7%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Aug 14What You Can Learn From Cosmax, Inc.'s (KRX:192820) P/E After Its 27% Share Price CrashKOSE:A192820 1 Year Share Price vs Fair Value Explore Cosmax's Fair Values from the Community and select yours Cosmax...Major Estimate Revision • Aug 13Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩2.55b to ₩2.52b. EPS estimate also fell from ₩11,353 per share to ₩10,172 per share. Net income forecast to grow 67% next year vs 32% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩295,167 to ₩288,000. Share price fell 25% to ₩191,600 over the past week.Valuation Update With 7 Day Price Move • Aug 12Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩196,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 188% over the past three years.분석 기사 • Aug 04We Think Cosmax (KRX:192820) Might Have The DNA Of A Multi-BaggerIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...분석 기사 • Jul 21When Should You Buy Cosmax, Inc. (KRX:192820)?Cosmax, Inc. ( KRX:192820 ), might not be a large cap stock, but it led the KOSE gainers with a relatively large price...분석 기사 • Jun 23Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 29% Share Price SurgeDespite an already strong run, Cosmax, Inc. ( KRX:192820 ) shares have been powering on, with a gain of 29% in the last...Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩278,500, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 397% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩393,577 per share.Price Target Changed • Jun 18Price target increased by 9.5% to ₩261,571Up from ₩238,952, the current price target is an average from 21 analysts. New target price is approximately in line with last closing price of ₩262,000. Stock is up 40% over the past year. The company is forecast to post earnings per share of ₩11,419 for next year compared to ₩7,562 last year.Price Target Changed • May 19Price target increased by 7.1% to ₩227,714Up from ₩212,667, the current price target is an average from 21 analysts. New target price is 11% above last closing price of ₩205,000. Stock is up 24% over the past year. The company is forecast to post earnings per share of ₩11,055 for next year compared to ₩7,562 last year.Valuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩214,000, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total returns to shareholders of 244% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩424,696 per share.분석 기사 • May 09Cosmax, Inc.'s (KRX:192820) 29% Jump Shows Its Popularity With InvestorsThe Cosmax, Inc. ( KRX:192820 ) share price has done very well over the last month, posting an excellent gain of 29...분석 기사 • Apr 28These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt Reasonably WellDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...분석 기사 • Mar 26We Think That There Are Issues Underlying Cosmax's (KRX:192820) EarningsCosmax, Inc. ( KRX:192820 ) announced strong profits, but the stock was stagnant. Our analysis suggests that this might...New Risk • Mar 23New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.3% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.Reported Earnings • Mar 21Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: ₩7,562 (up from ₩5,036 in FY 2023). Revenue: ₩2.17t (up 22% from FY 2023). Net income: ₩85.8b (up 50% from FY 2023). Profit margin: 4.0% (up from 3.2% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Mar 19With Cosmax, Inc. (KRX:192820) It Looks Like You'll Get What You Pay ForWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 12x, you may consider...공시 • Mar 06Cosmax, Inc., Annual General Meeting, Mar 27, 2025Cosmax, Inc., Annual General Meeting, Mar 27, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 46, jeyak gongdan2-gil, hyangnam-eup, gyeonggi-do, hwaseong South KoreaPrice Target Changed • Mar 04Price target increased by 7.5% to ₩208,300Up from ₩193,789, the current price target is an average from 20 analysts. New target price is 25% above last closing price of ₩166,100. Stock is up 58% over the past year. The company is forecast to post earnings per share of ₩8,488 for next year compared to ₩5,036 last year.분석 기사 • Jan 20We Think Cosmax (KRX:192820) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...분석 기사 • Dec 15Cosmax (KRX:192820) Might Have The Makings Of A Multi-BaggerThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...분석 기사 • Nov 27Getting In Cheap On Cosmax, Inc. (KRX:192820) Might Be DifficultCosmax, Inc.'s ( KRX:192820 ) price-to-earnings (or "P/E") ratio of 19.9x might make it look like a strong sell right...Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩153,900, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 29% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,839 per share.Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩145,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 21% over the past three years.분석 기사 • Sep 13There's Been No Shortage Of Growth Recently For Cosmax's (KRX:192820) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...Price Target Changed • Aug 31Price target decreased by 8.0% to ₩187,625Down from ₩204,000, the current price target is an average from 16 analysts. New target price is 55% above last closing price of ₩121,300. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩9,550 for next year compared to ₩5,036 last year.분석 기사 • Aug 07Cosmax, Inc. (KRX:192820) Stocks Pounded By 32% But Not Lagging Market On Growth Or PricingCosmax, Inc. ( KRX:192820 ) shareholders won't be pleased to see that the share price has had a very rough month...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩128,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 7.0% over the past three years.New Risk • Jul 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (61% net debt to equity). Share price has been volatile over the past 3 months (7.6% average weekly change).Valuation Update With 7 Day Price Move • Jul 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩147,700, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,767 per share.분석 기사 • Jul 19Cosmax, Inc. (KRX:192820) Shares Could Be 43% Below Their Intrinsic Value EstimateKey Insights The projected fair value for Cosmax is ₩294,340 based on 2 Stage Free Cash Flow to Equity Current share...Price Target Changed • Jul 17Price target increased by 7.6% to ₩213,000Up from ₩198,000, the current price target is an average from 16 analysts. New target price is 20% above last closing price of ₩178,200. Stock is up 87% over the past year. The company is forecast to post earnings per share of ₩10,778 for next year compared to ₩5,036 last year.Buy Or Sell Opportunity • Jul 01Now 24% undervaluedOver the last 90 days, the stock has risen 48% to ₩189,100. The fair value is estimated to be ₩250,445, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 118% in the next 2 years.Buy Or Sell Opportunity • Jun 20Now 24% undervaluedOver the last 90 days, the stock has risen 57% to ₩177,700. The fair value is estimated to be ₩233,143, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 117% in the next 2 years.분석 기사 • Jun 18Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩188,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total returns to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩232,865 per share.분석 기사 • May 21Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 28% Share Price SurgeCosmax, Inc. ( KRX:192820 ) shares have continued their recent momentum with a 28% gain in the last month alone. The...Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩160,500, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩184,606 per share.Buy Or Sell Opportunity • Apr 26Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 8.4% to ₩134,500. The fair value is estimated to be ₩111,627, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.Buy Or Sell Opportunity • Apr 19Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to ₩135,300. The fair value is estimated to be ₩110,546, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.분석 기사 • Apr 18We Like These Underlying Return On Capital Trends At Cosmax (KRX:192820)What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...분석 기사 • Mar 27Statutory Profit Doesn't Reflect How Good Cosmax's (KRX:192820) Earnings AreCosmax, Inc.'s ( KRX:192820 ) strong earnings report was rewarded with a positive stock price move. We did some digging...분석 기사 • Mar 20Cosmax, Inc.'s (KRX:192820) Share Price Matching Investor OpinionWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 14x, you may consider...분석 기사 • Feb 29We Think Cosmax (KRX:192820) Is Taking Some Risk With Its DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Major Estimate Revision • Nov 14Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩8,136 to ₩7,241 per share. Revenue forecast steady at ₩1.81b. Net income forecast to grow 232% next year vs 78% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩163,533 unchanged from last update. Share price fell 12% to ₩121,300 over the past week.Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩131,400, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩81,014 per share.Major Estimate Revision • Aug 12Consensus EPS estimates increase by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from ₩1.79b to ₩1.84b. EPS estimate increased from ₩6,844 to ₩7,573 per share. Net income forecast to grow 625% next year vs 125% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩118,714 to ₩141,786. Share price rose 28% to ₩133,100 over the past week.Price Target Changed • Aug 11Price target increased by 11% to ₩132,214Up from ₩118,714, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of ₩133,100. Stock is up 97% over the past year. The company is forecast to post earnings per share of ₩6,982 for next year compared to ₩1,838 last year.Price Target Changed • Jul 22Price target increased by 7.7% to ₩117,571Up from ₩109,214, the current price target is an average from 14 analysts. New target price is 20% above last closing price of ₩98,000. Stock is up 38% over the past year. The company is forecast to post earnings per share of ₩6,844 for next year compared to ₩1,838 last year.Price Target Changed • Jun 01Price target increased by 8.2% to ₩108,143Up from ₩99,917, the current price target is an average from 14 analysts. New target price is 33% above last closing price of ₩81,100. Stock is up 17% over the past year. The company is forecast to post earnings per share of ₩6,595 for next year compared to ₩1,838 last year.Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩87,200, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 6.5% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩89,945 per share.Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩71,400, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩141,805 per share.Reported Earnings • Mar 26Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: ₩1,838 (down from ₩6,944 in FY 2021). Revenue: ₩1.60t (flat on FY 2021). Net income: ₩20.8b (down 72% from FY 2021). Profit margin: 1.3% (down from 4.7% in FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Price Target Changed • Mar 11Price target increased by 8.0% to ₩94,923Up from ₩87,923, the current price target is an average from 13 analysts. New target price is 18% above last closing price of ₩80,400. Stock is down 6.0% over the past year. The company is forecast to post earnings per share of ₩3,984 for next year compared to ₩6,944 last year.Major Estimate Revision • Jan 27Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from ₩4,579 to ₩4,062 per share. Revenue forecast steady at ₩1.62b. Net income forecast to grow 26% next year vs 122% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩83,692 to ₩87,000. Share price rose 2.0% to ₩79,900 over the past week.Upcoming Dividend • Dec 21Upcoming dividend of ₩550 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 07 April 2023. Payout ratio is a comfortable 12% but the company is paying out more than the cash it is generating. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (1.3%).Price Target Changed • Dec 14Price target decreased to ₩75,692Down from ₩81,571, the current price target is an average from 13 analysts. New target price is 13% above last closing price of ₩67,000. Stock is down 34% over the past year. The company is forecast to post earnings per share of ₩4,524 for next year compared to ₩6,944 last year.Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩67,000, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years.Major Estimate Revision • Nov 16Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.66b to ₩1.62b. EPS estimate also fell from ₩4,954 per share to ₩4,372 per share. Net income forecast to grow 20% next year vs 41% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩81,571 to ₩77,231. Share price rose 14% to ₩59,100 over the past week.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩42,550, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 39% over the past three years.Price Target Changed • Oct 12Price target decreased to ₩93,357Down from ₩101,286, the current price target is an average from 14 analysts. New target price is 114% above last closing price of ₩43,550. Stock is down 67% over the past year. The company is forecast to post earnings per share of ₩5,160 for next year compared to ₩6,944 last year.Price Target Changed • Oct 08Price target decreased to ₩97,357Down from ₩107,571, the current price target is an average from 14 analysts. New target price is 97% above last closing price of ₩49,450. Stock is down 63% over the past year. The company is forecast to post earnings per share of ₩5,187 for next year compared to ₩6,944 last year.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩51,500, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years.Price Target Changed • May 19Price target decreased to ₩120,267Down from ₩131,938, the current price target is an average from 15 analysts. New target price is 89% above last closing price of ₩63,800. Stock is down 47% over the past year. The company is forecast to post earnings per share of ₩5,492 for next year compared to ₩6,944 last year.Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩63,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 41% over the past three years.Major Estimate Revision • May 17Consensus EPS estimates fall by 37%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.75b to ₩1.68b. EPS estimate also fell from ₩7,613 per share to ₩4,790 per share. Net income forecast to shrink 25% next year vs 22% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩131,938 to ₩124,933. Share price fell 18% to ₩63,600 over the past week.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Price Target Changed • Mar 10Price target decreased to ₩147,118Down from ₩159,125, the current price target is an average from 17 analysts. New target price is 75% above last closing price of ₩83,900. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₩6,416 for next year compared to ₩2,128 last year.Buying Opportunity • Jan 19Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 43%. The fair value is estimated to be ₩93,653, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% per annum over the last 3 years. Earnings per share has grown by 12% per annum over the last 3 years.Valuation Update With 7 Day Price Move • Dec 21Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩84,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total loss to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩102,416 per share.Price Target Changed • Aug 15Price target increased to ₩173,150Up from ₩161,632, the current price target is an average from 19 analysts. New target price is 30% above last closing price of ₩133,000. Stock is up 16% over the past year.공시 • Jun 26Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion.Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,300,000 Price\Range: KRW 103000 Transaction Features: ESOP Related Offering; Rights OfferingValuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩111,500, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩110,448 per share.분석 기사 • Apr 16Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Mar 25Investors Can Find Comfort In Cosmax's (KRX:192820) Earnings QualityThe market for Cosmax, Inc.'s ( KRX:192820 ) shares didn't move much after it posted weak earnings recently. Our...분석 기사 • Mar 10Will Cosmax (KRX:192820) Multiply In Value Going Forward?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...이익 및 매출 성장 예측KOSE:A192820 - 애널리스트 향후 추정치 및 과거 재무 데이터 (KRW Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20283,323,872212,072198,929262,9001512/31/20273,028,069167,656156,462245,4182412/31/20262,751,626147,103112,115194,093183/31/20262,492,207156,509-84,308158,564N/A12/31/20252,398,758123,064-105,90486,705N/A9/30/20252,355,75449,878-59,403143,045N/A6/30/20252,299,96961,978-158,87222,582N/A3/31/20252,227,86274,690-93,90785,991N/A12/31/20242,166,09085,797-95,55972,966N/A9/30/20242,044,78978,679-10,087135,964N/A6/30/20241,973,22372,86269,481196,158N/A3/31/20241,901,03669,67291,250184,499N/A12/31/20231,777,49457,137140,954231,021N/A9/30/20231,741,27435,14782,887160,859N/A6/30/20231,679,78431,22651,988153,723N/A3/31/20231,605,53412,26841,231135,594N/A12/31/20221,600,12620,84818,270102,531N/A9/30/20221,620,85953,27576572,042N/A6/30/20221,619,03653,13355,58995,319N/A3/31/20221,644,37773,65449,17890,445N/A12/31/20211,591,48874,43657,938100,046N/A9/30/20211,524,74549,73215,70368,883N/A6/30/20211,450,48844,39045,54097,307N/A3/31/20211,399,35032,64033,99593,000N/A12/31/20201,382,88121,378-18,44641,460N/A9/30/20201,381,48340,5951,22562,103N/A6/30/20201,378,24038,552-111,927-1,305N/A3/31/20201,331,33127,621-89,59217,305N/A12/31/20191,330,65331,823N/A74,567N/A9/30/20191,306,41928,290N/A5,681N/A6/30/20191,303,60929,761N/A30,008N/A3/31/20191,298,82932,302N/A-318N/A12/31/20181,259,71732,621N/A-54,592N/A9/30/20181,154,88928,078N/A-30,777N/A6/30/20181,048,77526,092N/A-36,262N/A3/31/2018953,54324,759N/A-16,433N/A12/31/2017883,95018,855N/A-6,617N/A9/30/2017859,62124,785N/A12,527N/A6/30/2017837,21328,191N/A10,850N/A3/31/2017802,62228,894N/A15,353N/A12/31/2016756,96434,782N/A23,469N/A9/30/2016701,78128,311N/A22,797N/A6/30/2016640,40227,328N/A18,506N/A3/31/2016590,43726,166N/A-11,262N/A12/31/2015533,34321,244N/A-6,503N/A9/30/2015565,34625,940N/A-13,870N/A6/30/2015531,87323,923N/A-14,161N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: A192820 의 연간 예상 수익 증가율(10.5%)이 saving rate(3.1%)보다 높습니다.수익 vs 시장: A192820 의 연간 수익(10.5%)이 KR 시장(29.4%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: A192820 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: A192820 의 수익(연간 10.3%)이 KR 시장(연간 16.6%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: A192820 의 수익(연간 10.3%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: A192820의 자본 수익률은 3년 후 23.4%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YHousehold 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/24 08:47종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Cosmax, Inc.는 34명의 분석가가 다루고 있습니다. 이 중 24명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Hyung-Joon MoonBarclaysJung Ae ChunBofA Global ResearchHyeryeong KimCGS International31명의 분석가 더 보기
Major Estimate Revision • Jan 27Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩6,824 to ₩5,749 per share. Revenue forecast steady at ₩2.40b. Net income forecast to grow 149% next year vs 61% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩242,500. Share price rose 2.9% to ₩189,600 over the past week.
Price Target Changed • Nov 12Price target decreased by 10% to ₩256,280Down from ₩285,600, the current price target is an average from 25 analysts. New target price is 62% above last closing price of ₩158,000. Stock is up 19% over the past year. The company is forecast to post earnings per share of ₩6,484 for next year compared to ₩7,562 last year.
Major Estimate Revision • Nov 11Consensus EPS estimates fall by 28%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩9,309 to ₩6,713 per share. Revenue forecast steady at ₩2.45b. Net income forecast to grow 92% next year vs 72% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩280,160. Share price fell 22% to ₩156,500 over the past week.
Major Estimate Revision • Aug 13Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩2.55b to ₩2.52b. EPS estimate also fell from ₩11,353 per share to ₩10,172 per share. Net income forecast to grow 67% next year vs 32% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩295,167 to ₩288,000. Share price fell 25% to ₩191,600 over the past week.
Price Target Changed • Jun 18Price target increased by 9.5% to ₩261,571Up from ₩238,952, the current price target is an average from 21 analysts. New target price is approximately in line with last closing price of ₩262,000. Stock is up 40% over the past year. The company is forecast to post earnings per share of ₩11,419 for next year compared to ₩7,562 last year.
Price Target Changed • May 19Price target increased by 7.1% to ₩227,714Up from ₩212,667, the current price target is an average from 21 analysts. New target price is 11% above last closing price of ₩205,000. Stock is up 24% over the past year. The company is forecast to post earnings per share of ₩11,055 for next year compared to ₩7,562 last year.
Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩180,200, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 115% over the past three years.
분석 기사 • Mar 25Cosmax's (KRX:192820) Solid Profits Have Weak FundamentalsCosmax, Inc.'s ( KRX:192820 ) stock was strong after they recently reported robust earnings. However, our analysis...
Reported Earnings • Mar 24Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: ₩10,847 (up from ₩7,562 in FY 2024). Revenue: ₩2.40t (up 11% from FY 2024). Net income: ₩123.1b (up 43% from FY 2024). Profit margin: 5.1% (up from 4.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 95%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩198,700, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 157% over the past three years.
공시 • Mar 07+ 1 more updateCosmax, Inc. announces Annual dividendCosmax, Inc. announced Annual dividend of KRW 3300.0000 per share, ex-date on March 30, 2026 and record date on March 31, 2026.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩160,700, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 102% over the past three years.
공시 • Feb 23Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl.Cosmax, Inc. (KOSE:A192820) signed a share purchase agreement to acquire 51% stake in Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl on February 23, 2026. Through this acquisition, COSMAX seeks to leverage the strengths of both companies to create significant synergies. For the period ending December 31, 2025, Keminova Italiana A Responsabilita' Limitata Benefit In Breve Keminova Italiana S.B. Srl reported total revenue of €10.5 million. COSMAX plans to satisfy the conditions precedent, including securing approval from the Italian government, by March, to finalize the transaction.
Major Estimate Revision • Jan 27Consensus EPS estimates fall by 16%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩6,824 to ₩5,749 per share. Revenue forecast steady at ₩2.40b. Net income forecast to grow 149% next year vs 61% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩242,500. Share price rose 2.9% to ₩189,600 over the past week.
분석 기사 • Jan 02These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • Dec 17Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) P/EWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 13x, you may consider...
분석 기사 • Nov 20We Like Cosmax's (KRX:192820) Returns And Here's How They're TrendingIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...
Reported Earnings • Nov 19Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: ₩789 (down from ₩1,856 in 3Q 2024). Revenue: ₩585.6b (up 11% from 3Q 2024). Net income: ₩8.96b (down 57% from 3Q 2024). Profit margin: 1.5% (down from 4.0% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 76%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • Nov 12Price target decreased by 10% to ₩256,280Down from ₩285,600, the current price target is an average from 25 analysts. New target price is 62% above last closing price of ₩158,000. Stock is up 19% over the past year. The company is forecast to post earnings per share of ₩6,484 for next year compared to ₩7,562 last year.
Major Estimate Revision • Nov 11Consensus EPS estimates fall by 28%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from ₩9,309 to ₩6,713 per share. Revenue forecast steady at ₩2.45b. Net income forecast to grow 92% next year vs 72% growth forecast for Personal Products industry in South Korea. Consensus price target broadly unchanged at ₩280,160. Share price fell 22% to ₩156,500 over the past week.
분석 기사 • Nov 05When Should You Buy Cosmax, Inc. (KRX:192820)?Cosmax, Inc. ( KRX:192820 ), is not the largest company out there, but it saw significant share price movement during...
분석 기사 • Sep 17Is Cosmax, Inc. (KRX:192820) Trading At A 47% Discount?Key Insights Cosmax's estimated fair value is ₩417,766 based on 2 Stage Free Cash Flow to Equity Cosmax's ₩222,500...
분석 기사 • Sep 03These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt Reasonably WellLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
New Risk • Aug 19New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (2.6% operating cash flow to total debt). High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change).
Reported Earnings • Aug 19Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: ₩1,844 (down from ₩2,965 in 2Q 2024). Revenue: ₩623.6b (up 13% from 2Q 2024). Net income: ₩20.9b (down 38% from 2Q 2024). Profit margin: 3.4% (down from 6.1% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.7%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Aug 14What You Can Learn From Cosmax, Inc.'s (KRX:192820) P/E After Its 27% Share Price CrashKOSE:A192820 1 Year Share Price vs Fair Value Explore Cosmax's Fair Values from the Community and select yours Cosmax...
Major Estimate Revision • Aug 13Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from ₩2.55b to ₩2.52b. EPS estimate also fell from ₩11,353 per share to ₩10,172 per share. Net income forecast to grow 67% next year vs 32% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩295,167 to ₩288,000. Share price fell 25% to ₩191,600 over the past week.
Valuation Update With 7 Day Price Move • Aug 12Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to ₩196,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 188% over the past three years.
분석 기사 • Aug 04We Think Cosmax (KRX:192820) Might Have The DNA Of A Multi-BaggerIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
분석 기사 • Jul 21When Should You Buy Cosmax, Inc. (KRX:192820)?Cosmax, Inc. ( KRX:192820 ), might not be a large cap stock, but it led the KOSE gainers with a relatively large price...
분석 기사 • Jun 23Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 29% Share Price SurgeDespite an already strong run, Cosmax, Inc. ( KRX:192820 ) shares have been powering on, with a gain of 29% in the last...
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩278,500, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 397% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩393,577 per share.
Price Target Changed • Jun 18Price target increased by 9.5% to ₩261,571Up from ₩238,952, the current price target is an average from 21 analysts. New target price is approximately in line with last closing price of ₩262,000. Stock is up 40% over the past year. The company is forecast to post earnings per share of ₩11,419 for next year compared to ₩7,562 last year.
Price Target Changed • May 19Price target increased by 7.1% to ₩227,714Up from ₩212,667, the current price target is an average from 21 analysts. New target price is 11% above last closing price of ₩205,000. Stock is up 24% over the past year. The company is forecast to post earnings per share of ₩11,055 for next year compared to ₩7,562 last year.
Valuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 23%After last week's 23% share price gain to ₩214,000, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 12x in the Personal Products industry in South Korea. Total returns to shareholders of 244% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩424,696 per share.
분석 기사 • May 09Cosmax, Inc.'s (KRX:192820) 29% Jump Shows Its Popularity With InvestorsThe Cosmax, Inc. ( KRX:192820 ) share price has done very well over the last month, posting an excellent gain of 29...
분석 기사 • Apr 28These 4 Measures Indicate That Cosmax (KRX:192820) Is Using Debt Reasonably WellDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • Mar 26We Think That There Are Issues Underlying Cosmax's (KRX:192820) EarningsCosmax, Inc. ( KRX:192820 ) announced strong profits, but the stock was stagnant. Our analysis suggests that this might...
New Risk • Mar 23New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.3% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.
Reported Earnings • Mar 21Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: ₩7,562 (up from ₩5,036 in FY 2023). Revenue: ₩2.17t (up 22% from FY 2023). Net income: ₩85.8b (up 50% from FY 2023). Profit margin: 4.0% (up from 3.2% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.9%. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Mar 19With Cosmax, Inc. (KRX:192820) It Looks Like You'll Get What You Pay ForWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 12x, you may consider...
공시 • Mar 06Cosmax, Inc., Annual General Meeting, Mar 27, 2025Cosmax, Inc., Annual General Meeting, Mar 27, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 46, jeyak gongdan2-gil, hyangnam-eup, gyeonggi-do, hwaseong South Korea
Price Target Changed • Mar 04Price target increased by 7.5% to ₩208,300Up from ₩193,789, the current price target is an average from 20 analysts. New target price is 25% above last closing price of ₩166,100. Stock is up 58% over the past year. The company is forecast to post earnings per share of ₩8,488 for next year compared to ₩5,036 last year.
분석 기사 • Jan 20We Think Cosmax (KRX:192820) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
분석 기사 • Dec 15Cosmax (KRX:192820) Might Have The Makings Of A Multi-BaggerThere are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...
분석 기사 • Nov 27Getting In Cheap On Cosmax, Inc. (KRX:192820) Might Be DifficultCosmax, Inc.'s ( KRX:192820 ) price-to-earnings (or "P/E") ratio of 19.9x might make it look like a strong sell right...
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩153,900, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total returns to shareholders of 29% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,839 per share.
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩145,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 21% over the past three years.
분석 기사 • Sep 13There's Been No Shortage Of Growth Recently For Cosmax's (KRX:192820) Returns On CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Price Target Changed • Aug 31Price target decreased by 8.0% to ₩187,625Down from ₩204,000, the current price target is an average from 16 analysts. New target price is 55% above last closing price of ₩121,300. Stock is down 20% over the past year. The company is forecast to post earnings per share of ₩9,550 for next year compared to ₩5,036 last year.
분석 기사 • Aug 07Cosmax, Inc. (KRX:192820) Stocks Pounded By 32% But Not Lagging Market On Growth Or PricingCosmax, Inc. ( KRX:192820 ) shareholders won't be pleased to see that the share price has had a very rough month...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩128,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 7.0% over the past three years.
New Risk • Jul 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (61% net debt to equity). Share price has been volatile over the past 3 months (7.6% average weekly change).
Valuation Update With 7 Day Price Move • Jul 19Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₩147,700, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩288,767 per share.
분석 기사 • Jul 19Cosmax, Inc. (KRX:192820) Shares Could Be 43% Below Their Intrinsic Value EstimateKey Insights The projected fair value for Cosmax is ₩294,340 based on 2 Stage Free Cash Flow to Equity Current share...
Price Target Changed • Jul 17Price target increased by 7.6% to ₩213,000Up from ₩198,000, the current price target is an average from 16 analysts. New target price is 20% above last closing price of ₩178,200. Stock is up 87% over the past year. The company is forecast to post earnings per share of ₩10,778 for next year compared to ₩5,036 last year.
Buy Or Sell Opportunity • Jul 01Now 24% undervaluedOver the last 90 days, the stock has risen 48% to ₩189,100. The fair value is estimated to be ₩250,445, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 118% in the next 2 years.
Buy Or Sell Opportunity • Jun 20Now 24% undervaluedOver the last 90 days, the stock has risen 57% to ₩177,700. The fair value is estimated to be ₩233,143, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has declined by 6.6%. Revenue is forecast to grow by 34% in 2 years. Earnings are forecast to grow by 117% in the next 2 years.
분석 기사 • Jun 18Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩188,600, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Personal Products industry in South Korea. Total returns to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩232,865 per share.
분석 기사 • May 21Why Investors Shouldn't Be Surprised By Cosmax, Inc.'s (KRX:192820) 28% Share Price SurgeCosmax, Inc. ( KRX:192820 ) shares have continued their recent momentum with a 28% gain in the last month alone. The...
Valuation Update With 7 Day Price Move • May 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩160,500, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩184,606 per share.
Buy Or Sell Opportunity • Apr 26Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 8.4% to ₩134,500. The fair value is estimated to be ₩111,627, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.
Buy Or Sell Opportunity • Apr 19Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 12% to ₩135,300. The fair value is estimated to be ₩110,546, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has declined by 7.4%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.
분석 기사 • Apr 18We Like These Underlying Return On Capital Trends At Cosmax (KRX:192820)What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
분석 기사 • Mar 27Statutory Profit Doesn't Reflect How Good Cosmax's (KRX:192820) Earnings AreCosmax, Inc.'s ( KRX:192820 ) strong earnings report was rewarded with a positive stock price move. We did some digging...
분석 기사 • Mar 20Cosmax, Inc.'s (KRX:192820) Share Price Matching Investor OpinionWhen close to half the companies in Korea have price-to-earnings ratios (or "P/E's") below 14x, you may consider...
분석 기사 • Feb 29We Think Cosmax (KRX:192820) Is Taking Some Risk With Its DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Major Estimate Revision • Nov 14Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from ₩8,136 to ₩7,241 per share. Revenue forecast steady at ₩1.81b. Net income forecast to grow 232% next year vs 78% growth forecast for Personal Products industry in South Korea. Consensus price target of ₩163,533 unchanged from last update. Share price fell 12% to ₩121,300 over the past week.
Valuation Update With 7 Day Price Move • Oct 18Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩131,400, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩81,014 per share.
Major Estimate Revision • Aug 12Consensus EPS estimates increase by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has improved. 2023 revenue forecast increased from ₩1.79b to ₩1.84b. EPS estimate increased from ₩6,844 to ₩7,573 per share. Net income forecast to grow 625% next year vs 125% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩118,714 to ₩141,786. Share price rose 28% to ₩133,100 over the past week.
Price Target Changed • Aug 11Price target increased by 11% to ₩132,214Up from ₩118,714, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of ₩133,100. Stock is up 97% over the past year. The company is forecast to post earnings per share of ₩6,982 for next year compared to ₩1,838 last year.
Price Target Changed • Jul 22Price target increased by 7.7% to ₩117,571Up from ₩109,214, the current price target is an average from 14 analysts. New target price is 20% above last closing price of ₩98,000. Stock is up 38% over the past year. The company is forecast to post earnings per share of ₩6,844 for next year compared to ₩1,838 last year.
Price Target Changed • Jun 01Price target increased by 8.2% to ₩108,143Up from ₩99,917, the current price target is an average from 14 analysts. New target price is 33% above last closing price of ₩81,100. Stock is up 17% over the past year. The company is forecast to post earnings per share of ₩6,595 for next year compared to ₩1,838 last year.
Valuation Update With 7 Day Price Move • May 16Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩87,200, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 19x in the Personal Products industry in South Korea. Total loss to shareholders of 6.5% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩89,945 per share.
Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩71,400, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩141,805 per share.
Reported Earnings • Mar 26Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: ₩1,838 (down from ₩6,944 in FY 2021). Revenue: ₩1.60t (flat on FY 2021). Net income: ₩20.8b (down 72% from FY 2021). Profit margin: 1.3% (down from 4.7% in FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 54%. Revenue is forecast to grow 9.7% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Personal Products industry in South Korea. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Mar 11Price target increased by 8.0% to ₩94,923Up from ₩87,923, the current price target is an average from 13 analysts. New target price is 18% above last closing price of ₩80,400. Stock is down 6.0% over the past year. The company is forecast to post earnings per share of ₩3,984 for next year compared to ₩6,944 last year.
Major Estimate Revision • Jan 27Consensus EPS estimates fall by 11%The consensus outlook for fiscal year 2022 has been updated. 2022 EPS estimate fell from ₩4,579 to ₩4,062 per share. Revenue forecast steady at ₩1.62b. Net income forecast to grow 26% next year vs 122% growth forecast for Personal Products industry in South Korea. Consensus price target up from ₩83,692 to ₩87,000. Share price rose 2.0% to ₩79,900 over the past week.
Upcoming Dividend • Dec 21Upcoming dividend of ₩550 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 07 April 2023. Payout ratio is a comfortable 12% but the company is paying out more than the cash it is generating. Trailing yield: 0.8%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (1.3%).
Price Target Changed • Dec 14Price target decreased to ₩75,692Down from ₩81,571, the current price target is an average from 13 analysts. New target price is 13% above last closing price of ₩67,000. Stock is down 34% over the past year. The company is forecast to post earnings per share of ₩4,524 for next year compared to ₩6,944 last year.
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩67,000, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 11% over the past three years.
Major Estimate Revision • Nov 16Consensus EPS estimates fall by 12%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.66b to ₩1.62b. EPS estimate also fell from ₩4,954 per share to ₩4,372 per share. Net income forecast to grow 20% next year vs 41% growth forecast for Personal Products industry in South Korea. Consensus price target down from ₩81,571 to ₩77,231. Share price rose 14% to ₩59,100 over the past week.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩42,550, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 39% over the past three years.
Price Target Changed • Oct 12Price target decreased to ₩93,357Down from ₩101,286, the current price target is an average from 14 analysts. New target price is 114% above last closing price of ₩43,550. Stock is down 67% over the past year. The company is forecast to post earnings per share of ₩5,160 for next year compared to ₩6,944 last year.
Price Target Changed • Oct 08Price target decreased to ₩97,357Down from ₩107,571, the current price target is an average from 14 analysts. New target price is 97% above last closing price of ₩49,450. Stock is down 63% over the past year. The company is forecast to post earnings per share of ₩5,187 for next year compared to ₩6,944 last year.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩51,500, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years.
Price Target Changed • May 19Price target decreased to ₩120,267Down from ₩131,938, the current price target is an average from 15 analysts. New target price is 89% above last closing price of ₩63,800. Stock is down 47% over the past year. The company is forecast to post earnings per share of ₩5,492 for next year compared to ₩6,944 last year.
Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to ₩63,500, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Personal Products industry in South Korea. Total loss to shareholders of 41% over the past three years.
Major Estimate Revision • May 17Consensus EPS estimates fall by 37%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from ₩1.75b to ₩1.68b. EPS estimate also fell from ₩7,613 per share to ₩4,790 per share. Net income forecast to shrink 25% next year vs 22% growth forecast for Personal Products industry in South Korea . Consensus price target down from ₩131,938 to ₩124,933. Share price fell 18% to ₩63,600 over the past week.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Price Target Changed • Mar 10Price target decreased to ₩147,118Down from ₩159,125, the current price target is an average from 17 analysts. New target price is 75% above last closing price of ₩83,900. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₩6,416 for next year compared to ₩2,128 last year.
Buying Opportunity • Jan 19Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 43%. The fair value is estimated to be ₩93,653, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% per annum over the last 3 years. Earnings per share has grown by 12% per annum over the last 3 years.
Valuation Update With 7 Day Price Move • Dec 21Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩84,700, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Personal Products industry in South Korea. Total loss to shareholders of 30% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩102,416 per share.
Price Target Changed • Aug 15Price target increased to ₩173,150Up from ₩161,632, the current price target is an average from 19 analysts. New target price is 30% above last closing price of ₩133,000. Stock is up 16% over the past year.
공시 • Jun 26Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion.Cosmax, Inc. has completed a Follow-on Equity Offering in the amount of KRW 133.9 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 1,300,000 Price\Range: KRW 103000 Transaction Features: ESOP Related Offering; Rights Offering
Valuation Update With 7 Day Price Move • Apr 28Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₩111,500, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 28% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₩110,448 per share.
분석 기사 • Apr 16Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Mar 25Investors Can Find Comfort In Cosmax's (KRX:192820) Earnings QualityThe market for Cosmax, Inc.'s ( KRX:192820 ) shares didn't move much after it posted weak earnings recently. Our...
분석 기사 • Mar 10Will Cosmax (KRX:192820) Multiply In Value Going Forward?If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...